Prevalence of pediatric dyslipidemia: Comparison of a population-based claims database to national surveys

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 10, 2010, Pages 1031-1040

  Li, Jie ^a   Motsko, Stephen P ^a   Goehring Jr , Earl L ^a   Tave, Arlene ^a   Pezzullo, John C ^a   Jones, Judith K ^a  

^a The Degge Group Ltd   (United States)

Author keywords

Cholesterol; Claims database; Dyslipidemia; NHANES; Pediatric; Prevalence

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; DYSLIPIDEMIA; FEMALE; GENDER; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

ADOLESCENT; CHILD; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; DYSLIPIDEMIAS; FEMALE; HEALTH SURVEYS; HUMANS; LIPIDS; MALE; NUTRITION SURVEYS; POPULATION; PREVALENCE; TRIGLYCERIDES;

EID: 79251484329     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1982     Document Type: Article

References (39)

1. Ahmed SM, Clasen ME, Donnelly JE. Management of dyslipidemia in adults. Am Fam Physician 1998; 57: 2192-2198.
2. Berenson GS, Srinivasan SR, Bao W, Newman WP III, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 1998; 338: 1650-1656.
3. McCrindle BW. Hyperlipidemia in children. Thromb Res 2006; 118: 49-58.
4. McGill HC Jr, McMahan CA, Malcom GT, Oalmann MC, Strong JP. Effects of serum lipoproteins and smoking on atherosclerosis in young men and women. The PDAY Research Group. Pathobiological determinants of atherosclerosis in youth. Arterioscler Thromb Vasc Biol 1997; 17: 95-106.
5. Strong JP, McGill HC, Tejada C Jnr, Holman RL. The natural history of atherosclerosis; comparison of the early aortic lesions in New Orleans, Guatemala, and Costa Rica. Am J Pathol 1958; 34: 731-744.
6. Raitakari OT, Juonala M, Kahonen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the cardiovascular risk in Young Finns Study. JAMA 2003; 290: 2277-2283.
7. Hickman TB, Briefel RR, Carroll MD, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 1998; 27: 879-890.
8. Ford ES, Li C, Zhao G, Mokdad AH. Concentrations of low-density lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation 2009; 119: 1108-1115.
9. Johnson WD, Kroon JJ, Greenway FL, Bouchard C, Ryan D, Katzmarzyk PT. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006. Arch Pediatr Adolesc Med 2009; 163(4): 371-377.
10. Li J, Motsko SP, Goehring EL Jr, et al. Longitudinal study on pediatric dyslipidemia in population-based claims database. Pharmacoepidemiol Drug Saf 2010; 19: 90-98.
11. Liberman JN, Berger JE, Lewis M. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents. Arch Pediatr Adolesc Med 2009; 163(4): 357-364.
12. Koro C, Barrett S, Qizilbash N. Cancer risks in thiazolidinedione users compared to other anti-diabetic agents. Pharmacoepidemiol Drug Saf 2007; 16: 485-492.
13. Blumentals WA, Gomez-Caminero A, Joo S, Vannappagari V. Should erectile dysfunction be considered as a marker for acute myocardial infarction? Results from a retrospective cohort study. Int J Impot Res 2004; 16: 350-353.
14. Blumentals WA, Gomez-Caminero A, Brown RR, Vannappagari V, Russo LJ. A case-control study of erectile dysfunction among men diagnosed with panic disorder. Int J Impot Res 2004; 16: 299-302.
15. Sheehan DV, Eaddy MT, Shah MB, Mauch RP. Differences in total medical costs across the SSRIs for the treatment of depression and anxiety. Am J Manag Care 2005; 11: S354-S361.
16. Keene MS, Eaddy MT, Nelson WW, Sarnes MW. Adherence to paroxetine CR compared with paroxetine IR in a medicare-eligible population with anxiety disorders. Am J Manag Care 2005; 11: S362-S369.
17. Han E, Black LK, Lavelle JP. Incontinence related to management of benign prostatic hypertrophy. Am J Geriatr Pharmacother 2007; 5: 324-334.
18. Koro CE, Sowell MO, Stender M, Qizilbash N. The risk of myopathy associated with thiazolidinediones and statins in patients with type 2 diabetes: a nested case-control analysis. Clin Ther 2008; 30: 535-542.
19. Wu EQ, Mulani PM, Yu AP, Tang J, Pollack PF. Loss of treatment response to infliximab maintenance therapy in Crohn's disease: a payor perspective. Value Health 2008; 11: 820-829.
20. Shea AM, Curtis LH, Szczech LA, Schulman KA. Sensitivity of international classification of diseases codes for hyponatremia among commercially insured outpatients in the United States. BMC Nephrol 2008; 9: 5.
21. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data 1999-2000, 2001-2002, and 2003-2004. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention: Hyattsville, MD, 2005.
22. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295: 1549-55.
23. The Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey: Laboratory Procedures Manual. 2004.
24. National Center for Health Statistics. NHANES 1999-2000 Data Documentation Lab 13AM Triglycerides and LDL-Cholesterol. 2007.
25. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18. 499-502.
26. Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS). Specifying Weighting Parameters. NHANES Web Tutorial 2009. Available at: http://www.cdc.gov/nchs/tutorials/Nhanes/SurveyDesign/Weighting/intro.htm [accessed on 20 October 2009].
27. American Academy of Pediatrics. National Cholesterol Education Program: report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992; 89: 525-584.
28. National Cholesterol Education Program (NCEP): highlights of the report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992; 89: 495-501.
29. Jolliffe CJ, Janssen I. Distribution of lipoproteins by age and gender in adolescents. Circulation 2006; 114: 1056-1062.
30. Kavey RE, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr 2003; 142: 368-372.
31. Bachorik PS, Lovejoy KL, Carroll MD, Johnson CL. Apolipoprotein B and AI distributions in the United States, 1988-1991: results of the National Health and Nutrition Examination Survey III (NHANES III). Clin Chem 1997; 43(12): 2364-2378.
32. Magnussen CG, Raitakari OT, Thomson R, et al. Utility of currently recommended pediatric dyslipidemia classifications in predicting dyslipidemia in adulthood: evidence from the Childhood Determinants of Adult Health (CDAH) study, Cardiovascular Risk in Young Finns Study, and Bogalusa Heart Study. Circulation 2008; 117: 32-42.
33. Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007; 298: 299-308.
34. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007; 298: 309-316.
35. Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 2008; 300: 2142-2152.
36. Labarthe DR, Nichaman MZ, Harrist RB, Grunbaum JA, Dai S. Development of cardiovascular risk factors from ages 8 to 18 in Project HeartBeat! Study design and patterns of change in plasma total cholesterol concentration. Circulation 1997; 95: 2636-2642.
37. Morrison JA, Sprecher DL, Biro FM, Apperson-Hansen C, Dipaola LM. Serum testosterone associates with lower high-density lipoprotein cholesterol in black and white males, 10 to 15 years of age, through lowered apolipoprotein AI and AII concentrations. Metabolism 2002; 51: 432-437.
38. Laskarzewski PM, Morrison JA, Gutai J, Orchard T, Khoury PR, Glueck CJ. High and low density lipoprotein cholesterols in adolescent boys: relationships with endogenous testosterone, estradiol, and Quetelet index. Metabolism 1983; 32: 262-271.
39. Klein RJ, Proctor SE, Boudreault MA, Turczyn KM. Healthy People 2010 Criteria for Data Suppression. Statistical Notes, no 24. CDC National Center for Health Statistics. Hyattsville, Maryland 2002.